CVE-2026-34324

Received Received - Intake

Unauthorized Data Access via HTTP in Oracle Life Sciences InForm

Publication date: 2026-04-21

Last updated on: 2026-04-23

Assigner: Oracle

Description

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: App Server). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published

2026-04-21

Last Modified

2026-04-23

Generated

2026-07-06

AI Q&A

2026-04-22

EPSS Evaluated

2026-07-05

NVD

CVE-2026-34324

Affected Vendors & Products

Vendor	Product	Version / Range
oracle	life_sciences_inform	7.0.1.0
oracle	life_sciences_inform	7.0.1.1

Helpful Resources

Exploitability

CWE

KEV

CWE ID	Description
CWE-284	The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.

Attack-Flow Graph

Compliance Impact

This vulnerability allows an unauthenticated attacker to gain unauthorized read and write access to data within Oracle Life Sciences InForm. Such unauthorized access and modification of data can lead to violations of data protection and privacy regulations, including GDPR and HIPAA, which require strict controls over the confidentiality and integrity of sensitive information.

Specifically, the compromise of confidentiality and integrity of accessible data may result in non-compliance with requirements for protecting personal and health information, potentially leading to legal and regulatory consequences.

Executive Summary

This vulnerability exists in the Oracle Life Sciences InForm product, specifically in the App Server component of versions 7.0.1.0 and 7.0.1.1.

It allows an unauthenticated attacker with network access via HTTP to exploit the system easily.

Successful exploitation can lead to unauthorized ability to update, insert, or delete some accessible data, as well as unauthorized read access to a subset of accessible data within Oracle Life Sciences InForm.

Impact Analysis

The vulnerability can impact you by allowing an attacker without any authentication to access and modify data within Oracle Life Sciences InForm.

Unauthorized update, insert, or deletion of some accessible data.
Unauthorized read access to a subset of accessible data.

This could lead to data integrity issues and potential exposure of sensitive information.

Hi! I’m here to help you understand CVE-2026-34324. Ask me anything about the vulnerability, its impact, or mitigation strategies.

0/70